ACTRN12619001340123尚未招募未知
Systems performance and glucose control with the Medtronic advanced hybrid closed loop system (A-HCL) using insulin aspart vs faster acting insulin aspart (FiASP): Extension study evaluating meal-time glucose control
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Type 1 diabetes of >1 year duration
- •Stable on insulin pump therapy for >3 months
- •Proficient in carbohydrate counting
- •Continuous glucose monitoring (CGM) sensor experience
- •HbA1c <10.0%
排除标准
- •eGFR <40ml/min/1.73m2
- •History of diabetic ketoacidosis or severe hypoglycaemia in the last 3 months
- •Diabetic gastroparesis
研究者
相似试验
进行中（未招募）
不适用
FiASP vs. aspart using an advanced closed-loop systemMetabolic and Endocrine - Diabetestype 1 diabetesACTRN12619000469112Medtronic Diabetes24
尚未招募
Unknown
EVOLUTION trial (EValuating glucose contrOL Using a next generaTION automated insulin delivery algorithm in patients with type 1 and type 2 diabetes: EVOLUTION): Phase 4Type 1 diabetes mellitusACTRN12623000634673niversity of Otago24
已完成
Unknown
EVOLUTION trial (EValuating glucose contrOL Using a next generaTION automated insulin delivery algorithm in patients with type 1 and type 2 diabetes: EVOLUTION)Type 2 diabetes mellitusMetabolic and Endocrine - DiabetesType 1 diabetes mellitusACTRN12623000623695niversity of Otago20
已完成
不适用
The effect of blood glucose control by artificial endocrine pancreas on oxidative stress and postoperative AKIJPRN-UMIN000019725Tokushima University Hospital40
已完成
不适用
The effect of blood glucose control by artificial endocrine pancreas in patients undergoing cardiac surgery on postoperative AKIacute kidney injuryJPRN-UMIN000019691Tokushima University Hospital30